- Autolus, a UCL/UCLH spin out (Martin Pule) continues to focus on the commercialisation of CAR-T cell therapy in adult acute lymphoblastic leukaemia.
- Achilles Therapeutics is developing novel cancer immunotherapies targeting clonal neoantigens T cells (cNET therapy)
